The Shanghai aging study: Study design, baseline characteristics, and prevalence of dementia

Neuroepidemiology

Volumn 43, Issue 2, 2014, Pages 114-122

  Ding, Ding ^a   Zhao, Qianhua ^a   Guo, Qihao ^a   Meng, Haijiao ^a   Wang, Bei ^a   Yu, Peimin ^a   Luo, Jianfeng ^b   Zhou, Yan ^a   Yu, Lirong ^a   Zheng, Li ^a   Chu, Shuguang ^a   Mortimer, James A ^c   Borenstein, Amy R ^c   Hong, Zhen ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Aging, dementia; Cohort study; Epidemiological methods; Mild cognitive impairment; Neuropsychological tests; Prevalence rate

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; DNA;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; CHRONIC DISEASE; CLINICAL EVALUATION; COHORT ANALYSIS; CONSENSUS; DEMENTIA; DNA EXTRACTION; EDUCATIONAL STATUS; FEMALE; GENOTYPE; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PROSPECTIVE STUDY; RISK FACTOR; URBAN POPULATION; URINALYSIS; CHINA; GENETICS; MIDDLE AGED; PREVALENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; APOLIPOPROTEIN E4; CHINA; DEMENTIA; EPIDEMIOLOGIC RESEARCH DESIGN; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PREVALENCE; PROSPECTIVE STUDIES; URBAN POPULATION;

EID: 84910043353     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000366163     Document Type: Article

References (50)

1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP: The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 2013; 9: 63-75.
2. www.china.org.cn/opinion/2012-11/03/content-26993812.htm.
3. Zhang ZX, Zahner GE, Román GC, Liu J, Hong Z, Qu QM, Liu XH, Zhang XJ, Zhou B, Wu CB, Tang MN, Hong X, Li H: Dementia subtypes in China: prevalence in Beijing, Xian, Shanghai, and Chengdu. Arch Neurol 2005; 62: 447-453.
4. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment. Arch Neurol 1999; 56: 303-308.
5. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST: Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1133-1142.
6. http://english.cri.cn/6909/2013/03/21/2561s 755163.htm. One-quarter of Shanghai's population elderly.
7. World Health Organization: Physical status: the use and interpretation of anthropometry. Geneva, Switzerland: World Health Organization, 1995.
8. Shu XO, Yang G, Jin F, Liu D, Kushi L, Wen W, Gao YT, Zheng W: Validity and reproducibility of the food frequency questionnaire used in the Shanghai Women's Health Study. Eur J Clin Nutr 2004; 58: 17-23.
9. Zung WWK: A rating instrument for anxiety disorders. Psychosomatics 1971; 12: 371-379.
10. Zhang J, Norvilitis JM: Measuring Chinese psychological wellbeing with Western developed instruments. J Pers Assess 2002; 79: 492-511.
11. Tsai PS, Wang SY, Wang MY, Su CT, Yang TT, Huang CJ, Fang SC: Psychometric evaluation of the Chinese version of the Pittsburgh Sleep Quality Index (CPSQI) in primary insomnia and control subjects. Qual Life Res 2005; 14: 1943-1952.
12. Wang HM, Patrick DL, Edwards TC, Skalicky AM, Zeng HY, Gu WW: Validation of the EQ-5D in a general population sample in urban China. Qual Life Res 2012; 21: 155-160.
13. Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179-186.
14. Hachinski VC, Lassen NA, Marshall J: Multiinfarct dementia: a cause of mental deterioration in the elderly. Lancet 1974; 2: 207-210.
15. Morris JC: The clinical dementia rating (CDR): current version and scoring rules. Neurology 1993; 43: 2412-2414.
16. Lim WS, Chong MS, Sahadevan S: Utility of the clinical dementia rating in Asian populations. Clin Med Res 2007; 5: 61-70.
17. Zhang M, Katzman R, Salmon D, Jin H, Cai GJ, Wang ZY, Qu GY, Grant I, Yu E, Levy P: The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol 1990; 27: 428-437.
18. Dubois B, Slachevsky A, Litvan I, Pillon B: The FAB: a Frontal Assessment Battery at bedside. Neurology 2000; 55: 1621-1626.
19. Lezak MD, Howieson DB, Loring DW: Neuropsychological Assessment, ed 4. New York, Oxford University Press, 2004, pp 562-563.
20. Lezak MD, Howieson D, Loring DW, Howieson DB, Fischer JS: Neuropsychological Assessment, ed 4. London, Oxford University Press, 2004, p 583.
21. Guo Q, Zhao Q, Chen M, Ding D, Hong Z: A comparison study of mild cognitive impairment with 3 memory tests among Chinese individuals. Alzheimer Dis Assoc Disord 2009; 23: 253-259.
22. Fuld PA: Psychological testing in the differential diagnosis of the dementias; in Katzman R, Terry RD, Bick KL (eds): Alzheimer's disease: senile dementia and related disorders (Aging). New York, Raven Press, 1978, pp 690-691.
23. Lu J, Guo Q, Hong Z, Shi W, Lu C: Trail making test used by Chinese elderly patients with mild cognitive impairment and mild Alzheimer's dementia. Chinese Journal of Clinical Psychology 2006; 14: 118-121 (in Chinese).
24. Carnero-Pardo C, Gurpegui M, Sanchez-Cantalejo E, Frank A, Mola S, Barquero MS, Montoro-Rios MT; Trans-EURPTEST Group: Diagnostic accuracy of the Eurotest for dementia: a naturalistic, multicenter phase II study. BMC Neurol 2006; 6: 15.
25. Ding D, Zhao Q, Guo Q, Meng H, Wang B, Luo J, Mortimer JA, Borenstein AR, Hong Z: Prevalence of mild cognitive impairment in an urban community in China: a cross-sectional analysis of the Shanghai Aging Study. Alzheimers Dement 2014, DOI: 10.1016/j. jalz.2013.11.002. [Epub ahead of print] .
26. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994, pp 143-147.
27. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 25: 183-194.
28. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical-diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
29. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-260.
30. Smirnov DA, Morley M, Shin E, Spielman RS, Cheung VG: Genetic analysis of radiation-induced changes in human gene expression. Nature 2009; 459: 587-591.
31. Sachdev PS, Lipnicki DM, Crawford J, Reppermund S, Kochan NA, Trollor JN, Draper B, Slavin MJ, Kang K, Lux O, Mather KA, Brodaty H; Sydney Memory and Ageing Study Team: Risk profiles for mild cognitive impairment vary by age and sex: the Sydney Memory and Ageing Study. Am J Geriatr Psychiatry 2012; 20: 854-865.
32. Das SK, Bose P, Biswas A, Dutt A, Banerjee TK, Hazra AM, Raut DK, Chaudhuri A, Roy T: An epidemiologic study of mild cognitive impairment in Kolkata, India. Neurology 2007; 68: 2019-2026.
33. Busse A, Bischkopf J, Riedel-Heller SG, Angermeyer MC: Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria: results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Br J Psychiatry 2003; 182: 449-454.
34. Busse A, Hensel A, Guhne U, Angermeyer MC, Riedel-Heller SG: Mild cognitive impairment: long-term course of four clinical subtypes. Neurology 2006; 67: 2176-2185.
35. Di Carlo A, Lamassa M, Baldereschi M, Inzitari M, Scafato E, Farchi G, Inzitari D: CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology 2007; 68: 1909-1916.
36. Luck T, Riedel-Heller SG, Kaduszkiewicz H, Bickel H, Jessen F, Pentzek M, Wiese B, Koelsch H, van den Bussche H, Abholz HH, Moesch E, Gorfer S, Angermeyer MC, Maier W, Weyerer S; AgeCoDe group: Mild cognitive impairment in general practice: age-specific prevalence and correlate results from the German study on ageing, cognition and dementia in primary care patients (AgeCoDe). Dement Geriatr Cogn Disord 2007; 24: 307-316.
37. Palmer K, Backman L, Winblad B, Fratiglioni L: Mild cognitive impairment in the general population: occurrence and progression to Alzheimer's disease. Am J Geriatr Psychiatry 2008; 16: 603-611.
38. Manly JJ, Bell-McGinty S, Tang MX, Schupf N, Stern Y, Mayeux R: Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol 2005; 62: 1739-1746.
39. Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH: Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol 2003; 60: 1385-1389.
40. Roberts RO, Geda YE, Knopman DS, Cha RH, Pankratz VS, Boeve BF, Ivnik RJ, Tangalos EG, Petersen RC, Rocca WA: The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology 2008; 30: 58-69.
41. Petersen RC, Roberts RO, Knopman DS, Geda YE, Cha H, Pankratz VS, Boeve BF, Tangalos EG, Ivnik RJ, Rocca WA: Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology 2010; 75: 889-897.
42. Hu P, Qing YH, Jing CX, Lu L, Hu B, Du PF: Does the geographical gradient of ApoE4 allele exist in China? A systemic comparison among multiple Chinese populations. Mol Biol Rep 2011; 38: 489-494.
43. Liang S, Pan M, Geng HH, Chen H, Gu LQ, Qin XT, Jian JJ, Zhu JH, Liu CF: Apolipoprotein E polymorphism in normal Han Chinese population: frequency and effect on lipid parameters. Mol Biol Rep 2009; 36: 1251-1256.
44. Katzman R, Zhang MY, Chen PJ, Gu N, Jiang S, Saitoh T, Chen X, Klauber M, Thomas RG, Liu WT, Yu ES: Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia. Neurology 1997; 49: 779-785.
45. Jun G, Naj A, Beecham GW, Wang LS, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, Fallin MD, Friedland R, Inzelberg R, Kramer P, Rogaeva E, St George-Hyslop P; Alzheimer's Disease Genetics Consortium, Cantwell LB, Dombroski BA, Saykin AJ, Reiman EM, Bennett DA, Morris JC, Lunetta KL, Martin ER, Montine TJ, Goate AM, Blacker D, Tsuang DW, Beekly D, Cupples LA, Hakonarson H, Kukull W, Foroud TM, Haines J, Mayeux R, Farrer LA, Pericak-Vance MA, Schellenberg GD: Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer's disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 2010; 67: 1473-1484.
46. Dong MJ, Peng B, Lin XT, Zhao J, Zhou YR, Wang RH: The prevalence of dementia in the People's Republic of China: a systematic analysis of 1980-2004 studies. Age Ageing 2007; 36: 619-624.
47. Wu YT, Lee H, Norton S, Chen C, Chen H, He C, Fleming J, Matthews FE, Brayne C: Prevalence studies of dementia in mainland China, Hong Kong and Taiwan: a systematic review and meta-analysis. PLoS One 2013; 8 :e66252.
48. Chan KY, Wang WW, Wu JJ, Liu L, Theodoratou E, Car J, Middleton L, Russ TC, Deary IJ, Campbell H, Wang W, Rudan L; Global Health Epidemiology Reference Group (GHERG): Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet 2013; 381: 2016-2023.
49. Jia J, Wang F, Wei C, Zhou A, Jia X, Li F, Tang M, Chu L, Zhou Y, Zhou C, Cui Y, Wang Q, Wang W, Yin P, Hu N, Zuo X, Song H, Qin W, Wu L, Li D, Jia L, Song J, Han Y, Xing Y, Yang P, Li Y, Qiao Y, Tang Y, Lv J, Dong X: The prevalence of dementia in urban and rural areas of China. Alzheimers Dement 2014; 10: 1-9.
50. Pantoni L, Inzitari D: Pathological examination in vascular dementia. Am J Psychiatry 2002; 159: 1439-1440.